Previous 10 | Next 10 |
UnitedHealth’s ongoing acquisition of LHC Group is an interesting merger arbitrage setup, potentially offering an annualized return of 10%. The spread has recently widened as the transaction has attracted the FTC’s attention. The merger still seems likely to close - ...
Enhabit appears to be significantly undervalued compared to peers in the same line of business. On an absolute basis, Enhabit looks cheap compared to its future cash flows. As a recent spinoff, Enhabit has come under non-fundamental selling pressure. Thesis Enhabit, ...
BATON ROUGE, La., July 06, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the second quarter ended June 30, 2022, after the market closes on July 27, 2022. The Company wi...
Launching its coverage on Amedisys ( NASDAQ: AMED ) and Addus HomeCare ( ADUS ), Stifel issues a contrasting view on the two home health care companies after the Centers for Medicare and Medicaid Services (CMS) proposed cuts to Medicare home health rates last week. I...
HOUSTON and NASHVILLE, Tenn., June 24, 2022 (GLOBE NEWSWIRE) -- Memorial Hermann Health System is pleased to announce a new partnership with the nation's leading high-acuity home care provider Contessa, an Amedisys company (NASDAQ: AMED), to deliver home-based medical, rehabilitation an...
Amedisys (NASDAQ:AMED) stock fell ~13% on June 21 after Bank of America downgraded the stock to Underperform from Neutral with a price target of $102, from $145, following Centers for Medicare and Medicaid Services' (CMS) proposed cut to Medicare home health rates. Bofa Analyst Joanna Gajuk n...
Gainers: Convey Health Solutions CNVY +139%. Valneva VALN +87%. Clovis Oncology (CLVS) +34%. Innate Pharma (IPHA) +28%. Lexaria Bioscience (LEXX) +20%. Losers: ACADIA Pharmaceuticals ACAD -34%. Comera Life Sciences Holdings (CMRA) -17%. ...
Gainers: AN2 Therapeutics (ANTX) +7%. Design Therapeutics (DSGN) +6%. Edgio (EGIO) +5%. Humacyte (HUMA) +5%. Rhythm Pharmaceuticals (RYTM) +5%. Losers: Swvl Holdings (SWVL) -10%. Amedisys (AMED) -8%. Lilium (LILM) -5%. Centessa Pharmaceuticals (CNTA) -5%. KLX Energy Services Holding...
BATON ROUGE, La., June 09, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, has released its first Environmental, Social and Governance (ESG) Report for the year 2021, detailing actions, achievements and ...
DALLAS and NASHVILLE, Tenn., June 09, 2022 (GLOBE NEWSWIRE) -- Baylor Scott & White Health, the largest not-for-profit health system in Texas, and Contessa, an Amedisys company (NASDAQ: AMED) and the nation's leading high-acuity home care provider, announce a partnership to provide pati...
News, Short Squeeze, Breakout and More Instantly...
BATON ROUGE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024. Three-Month Periods Ended June 30, 2024 and 2023 Net service revenue increased $38.2 million to...
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Amedisys, Inc. (NASDAQ: AMED) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 3.74% on the day to $95.23. Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates thr...